We also observed that the USH2A mutation was associated with an increased tumor mutation burden (TMB) and tumor neoantigen burden (TNB) in our cohort (Figure S3), indicating that mutation in USH2A might be associated with an altered immune environment [20]. The gene discussed is USH2A; the disease is neoplasm.